Background mother to child, during pregnancy, delivery or breastfeeding. Prevention of mother-to-child transmission may be an effective Objectives children in this program.
families.
Strategies to prevent the transmission included maternal and infant ART therapy, elective caesarean section, and avoidance of breastfeeding. These combined interventions reduced the rate of transmission were women. 5 As more women were infected, the probability of passing the infection to their children 6 The rate of transmission was not evaluated again after this time. The objective of our study was to investigate the incidence of who had received prophylactic therapy at birth, as Methods department or other hospitals and aged less than 2 consisting of zidovudine for 6 weeks and a single dose parental consent. Maternal data collected included risk factors, mode and time of delivery, time of ART (before pregnancy, during pregnancy, during delivery, morbidities. After the age of 4 weeks, infection status of age, infection status was tested by serology. months of age. Uninfected infants underwent a age. Subjects who attended our clinic for less than 6 months were considered to be lost to follow up. Data
Results
There were 238 infants included in this study and of the infants of mothers who underwent complete during pregnancy, caesarean section, and formula which it decreased (Figure 1 Most subjects were male, full-term, and delivered by caesarean section in our hospital. The most frequently observed parental risk factor was intravenous drug use (Table 1 Maternal ART was given during pregnancy in most cases. Morbidities of our subjects were very low ( Table 2 respiratory tract infection, followed by acute diarrhea and dermatitis. All subjects survived.
Figure 1
ART during pregnancy was not given in four infants, while in the other two cases, mothers received intrapartum ART. Three of infected cases remain on active follow up and two of them were on second line ART ( Table 3 Discussion included nutritional management, prophylactic ART, as well as growth and developmental monitoring (Figure 2 7
There were 238 mother-infant pairs in our study.
decreased in subsequent years. The number of patients national program. Most infant subjects were male, full-term, and ery. Read et al 8 showed that elective caesarean section did not take ART or took only zidovudine. However, ed women who underwent caesarean than those who delivered vaginally. We did not evaluate postpartum morbidity in our study.
The most frequently observed parental risk factor effective for providing maternal virologic suppression, decreasing infant mortality, and reducing mother-tochild transmission. ART given for a minimum at 28 weeks gestation was more beneficial than that given short term.
depends on choice of nutrition (breastfeeding or non-breastfeeding infants should receive zidovudine or nevirapine from birth until 6 weeks of age. For for the mothers' own health and were breastfed, nevirapine should be given from birth until 6 weeks of age. However, if mothers do not need treatment for their own health and their babies are breastfed, babies should receive nevirapine from birth until one week
We gave ART to infants, consisting of zidovudine for 6 weeks at a dose of 2 mg/kg body weight and a single dose of nevirapine at 2 mg/kg body weight. 76 protocol and a study from Thailand. This we gave only zidovudine for 6 weeks.
2 Replacement feeding with infant formula prevents all transmission limited settings, formula feeding may also increase malnutrition, pneumonia, and diarrhea. Therefore, feeding must be evaluated in light of the risk of death formula fed, with consent from their parents. We 
